LianBio (LIANY): R&D Expense
Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$59.76M
Year ended 2022-12-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $59.76M | -62.3% | 2023-03-28, From 2022-01-01 |
| 2021-12-31 | $158.69M | +31.3% | 2023-03-28, From 2021-01-01 |
| 2020-12-31 | $120.89M | n/a | 2022-03-31, From 2020-01-01 |